1104455-41-5

Basic information

• Product Name: Methyl 4-chloro-5-Methylpicolinate
• Synonyms: Methyl 4-chloro-5-Methylpicolinate;4-Chloro-5-methylpyridine-2-carboxylic acid methyl ester
• CAS NO: 1104455-41-5
• Molecular Formula: C₈H₈ClNO₂
• Molecular Weight: 185.60762
• Mol File: 1104455-41-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 287.703 °C at 760 mmHg
• Flash Point: 127.799 °C
• Appearance: /
• Density: 1.248 g/cm³
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Methyl 4-chloro-5-Methylpicolinate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-chloro-5-Methylpicolinate(1104455-41-5)
• EPA Substance Registry System: Methyl 4-chloro-5-Methylpicolinate(1104455-41-5)

Safety Data

• Hazardous Substances Data: 1104455-41-5(Hazardous Substances Data)

Usage

General Description

Methyl 4-chloro-5-methylpicolinate is an organic compound with the molecular formula C7H6ClNO2. It is a chlorinated derivative of picolinic acid, the methyl ester of which is used in the synthesis of several pharmaceuticals and agrochemicals particularly herbicides. This substance appears as a pale yellow solid with its exact appearance varying depending upon the specific conditions and materials used in its production. Its properties can also be affected by exposure to air and moisture, and it may present some stability risks associated with light, heat and sparks or flames. It is not known to be particularly hazardous in terms of its health effects, but as with all chemicals, safe handling procedures should be followed to limit any potential risks.

Upstream product

• 401792-77-6 methyl 5-methyl-2-pyridinecarboxylate N-oxide 
• 67-56-1 methanol 
• 4434-13-3 2-carboxy-5-methylpyridine 

Relevant articles and documents

COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE

Provided herein, inter alia, are methods and compounds for modulating Interleukin-2-inducible T-cell kinase.

2,4-DIAMINO-PYRIMIDINE DERIVATIVES

The invention concerns compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, Q, R3, and R4 are as defined in the description. The present invention also relates to processes for the preparation ofsuch compounds, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours or other proliferative conditions which are sensitive to the inhibition of EphB4 kinases.